Verona Pharma PLC (VRNA)
14.93
-0.76
(-4.84%)
USD |
NASDAQ |
May 06, 16:00
14.93
0.00 (0.00%)
After-Hours: 20:00
Verona Pharma Cash from Investing (TTM): 0.00 for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | -0.029M |
December 31, 2022 | -0.029M |
September 30, 2022 | -0.03M |
June 30, 2022 | -0.041M |
March 31, 2022 | -0.012M |
December 31, 2021 | -0.012M |
September 30, 2021 | -0.02M |
June 30, 2021 | -0.077M |
March 31, 2021 | -0.077M |
December 31, 2020 | 9.71M |
Date | Value |
---|---|
September 30, 2020 | 8.016M |
June 30, 2020 | 30.65M |
March 31, 2020 | 45.32M |
December 31, 2019 | 47.31M |
September 30, 2019 | 44.54M |
June 30, 2019 | 10.62M |
March 31, 2019 | 12.24M |
December 31, 2018 | 6.701M |
September 30, 2018 | 17.72M |
June 30, 2018 | -2.581M |
March 31, 2018 | -60.57M |
December 31, 2017 | -66.85M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.077M
Minimum
Mar 2021
47.31M
Maximum
Dec 2019
10.31M
Average
--
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
Biodexa Pharmaceuticals Plc | -0.3289M |
NuCana PLC | 3.594M |
TC BioPharm (Holdings) PLC | -0.2614M |
Adaptimmune Therapeutics PLC | 176.54M |
Autolus Therapeutics PLC | -10.99M |